President Biden to Sign Executive Order Seeking New Prescription Drug Cost Savings
-Reuters Citing Official
https://www.reuters.com/world/us/biden-sign-order-seeking-new-prescription-drug-cost-savings-official-2022-10-14/
US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data — Trump’s SPAC Partner, Applied Materials And Chip Stocks In Focus Today
The U.S. index futures are pointing to a higher opening on Wall Street, reflecting traders’ hopes that the consumer price inflation data may prove benign.
FDA Approves GSK’s Whooping Cough Vaccine During Pregnancy For Prevention In Infants
The FDA has approved GSK Plc’s (NYSE:GSK) Boostrix vaccine during the third trimester of pregnancy to prevent whooping cough in infants…
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
The Biopharmaceutical Research Company (BRC), an active DEA pharmaceutical cannabis license holder, announced the completion of a $20 million Series A fundraise, that will enable the company to scale its operations and increase its product offering, conduct sponsored research, and execute on its go-to-market strategy.
AstraZeneca-Merck’s Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October’s Key PDUFA Catalysts Biotech Investors Must Know
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the total NME approvals for the year to 24. This is far less than the 40 approvals received by the same time last year.
2 High Yielders Decimated By The Russia-Ukraine War: Is Now The Time To Buy?
As the Russia-Ukraine war moves forward, the European economy remains in a fragile state.
Unilever CEO Alan Jope To Retire Next Year
British consumer goods giant Unilever PLC (NYSE:UL) Chief Executive Officer Alan Jope intends to retire in 2023 end. The decision comes after…
